(TheNewswire)
Co-Founder Justin Hanka t oDeliver Keynote Address
Provides Video Update After MicrodoseMolecular Masterclass
Vancouver, British Columbia – TheNewswire - March 08, 2022 –Blackhawk Growth Corp. (CSE:BLR ) ; (CNSX:BLR.CN); (OTC:BLRZF); ( Frankfurt:0JJ) (the“ Company ” or “ Blackhawk ”) is pleased to report thatMindBio Therapeutics (“MindBio”) is a key note presentor and majorsupporter of Plant Medicine Week in Malta.
Plant Medicine Week (plantmedicineweek.com) is being held in Valletta, Malta in April (5 th –8 th )to share diverse and inspiring perspectives of the latest advancesfrom the medical cannabis and psychedelics industries through casestudies, presentations, Q&A and exhibition.
Co-founder of MindBio Therapeutics, Justin Hanka, willbe sharing his perspectives on clinical trials, drug development andhis views on the responsibility to change the course of mental healthand the importance of investment in the sector. Recently Mr Hankaparticipated in Microdose Psychedelic Insights molecular masterclasson LSD (lysergic acid diethylamide) which can be viewed on Youtube .
MindBio Therapeutics is in the completion stages of aworld first clinical trial in 80 patients who are microdosing LSD athome. The Clinical Trial’s Independent Review Board and SafetyMonitoring Committee recently found no adverse events in the Phase 1clinical trial and approved it’s continuation, with almost 12 monthsof testing now complete. MindBio is now preparing for itscontinuation study, a Phase 2 clinical trial microdosing LSD inpatients with Major Depressive Disorder and a Phase 2 clinical trialmicrodosing LSD in late stage cancer patients experiencing existentialdistress, depression and anxiety.
MindBio is working towards creating a safe andeffective microdosing regimen using psychedelics that can beprescribed by doctors to patients in the primary health care systemwith the aim of changing the course of mental health .
“We are excited to support Plant Medicine Week inMalta and showcase our clinical trials microdosing psychedelicmedicines as MindBio prepares for its upcoming spin-out listing on theCanadian Securities Exchange” said Frederick Pels, CEO of Blackhawk.
Plant Medicine Week. More information and ticketsavailable here .
Microdose Molecular Masterclass video by MindBioCo-Founder Justin Hanka can be viewed on Youtube
About Blackhawk Growth
Blackhawk is an investment holding company looking tocreate substantial value for its shareholders through the acquisitionand development of high growth companies. It has focused itsinvestments in the health, cannabis and cannabidiol industries in bothCanada and the United States. Its portfolio of companies includes SacPharma, LeichtMind Clinics, Noble Hemp, Spaced Food, Stable Foods Co.,MindBio Therapeutics, Digital Mind Therapeuticsas well as an equity position in Gaia Grow Corp (CSE:GAIA).
The Company diligently posts updates through videosfrom the official company YouTube channel https://www.youtube.com/channel/UCs4f2tt3yAvOGhNLjgNOy-A
Please join the conversation on our Blackhawk groupsupporter’s telegram group at https://t.me/Blackhawkgrowthcorp and visit us online at https://www.blackhawkgrowth.com .
For further information please contact:
Frederick Pels, Chief ExecutiveOfficer
(403)-991-7737
fred@ blackhawkgrowth.com
Cautionary NoteRegarding Forward-Looking Statement
All statements in this pressrelease, other than statements of historical fact, are “forward-looking information”with respect to the Company within the meaning of applicablesecurities laws, including with respect to transaction and futureoperations of MindBio Therapeutics Pty Ltd. The Company providesforward-looking statements for the purpose of conveying informationabout current expectations and plans relating to the future andreaders are cautioned that such statements may not be appropriate forother purposes. By its nature, this information is subject to inherentrisks and uncertainties that may be general or specific and which giverise to the possibility that expectations, forecasts, predictions,projections or conclusions will not prove to be accurate, thatassumptions may not be correct and that objectives, strategic goalsand priorities will not be achieved. These risks and uncertaintiesinclude but are not limited those identified and reported in theCompany’s public filings under the Company’s SEDAR profile atwww.sedar.com. Although the Company has attempted to identifyimportant factors that could cause actual actions, events or resultsto differ materially from those described in forward-lookinginformation, there may be other factors that cause actions, events orresults not to be as anticipated, estimated or intended. There can beno assurance that such information will prove to be accurate as actualresults and future events could differ materially from thoseanticipated in such statements. The Company disclaims any intention orobligation to update or revise any forward-looking information,whether as a result of new information, future events or otherwiseunless required by law.
Copyright (c) 2022 TheNewswire - All rights reserved.